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The objective of this study was to prospectively assess the association between deployment in support of the operations in Iraq and
Afghanistan and newly reported lupus and rheumatoid arthritis while also considering the eﬀects of demographic, behavioral,
and occupational characteristics. A total of 77,047 (2001–2003) and 31,110 (2004–2006) participants completed the baseline
Millennium Cohort questionnaire and were resurveyed approximately every 3 years. Longitudinal analyses were used to assess
the adjusted association between deployment to Iraq and Afghanistan with and without combat exposures and newly reported
disease. After adjusting, deployment was not signiﬁcantly associated with newly reported lupus compared with nondeployers.
However, compared with nondeployers, deployers with and without combat exposures were signiﬁcantly less likely to newly report
rheumatoid arthritis. Women, non-Hispanic black, and Hispanic participants had a signiﬁcantly elevated risk for both diseases.
Overall, deployment was not associated with an increased risk of newly reported lupus or rheumatoid arthritis.
1.Introduction
Representing a diverse family of chronic disease, autoim-
mune diseases are disabling and have a variety of natural
histories. It is estimated that rheumatoid arthritis (RA)
and systemic lupus erythematosus (SLE) aﬀect considerable
numbers of US residents (460 per 100,000 persons and
40–150 per 100,000, resp.) [1–5]. The etiologies of these
conditions are unknown, and both diseases cause chronic,
systemic inﬂammation resulting in tissue and/or organ
damage [6]. Several studies document how these diseases
adversely aﬀect the general health of many in the US
population [2–5]; however, research is sparse in the US
military population on not only the frequency but also the
risk factors associated with their occurrence.
Military personnel deployed to combat regions during
the current operations in Iraq and Afghanistan are often
exposed to stressful situations putting this population at
higher risk for stress-related medical conditions and lifestyle
choices associated with poorer health outcomes [7–11].
T h e r eh a v eb e e nc o n c e r n sw i t hp r e v i o u sm i l i t a r yo p e r a t i o n s
that service members potentially have a higher risk of
SLE and RA due to traumatic stressors experienced during
deployment [12–14]. Furthermore, military personnel may
experience several environmental and occupational expo-
sures, including pesticides (environmental and topical),
paints,solvents,andsilicadustthathavebeenassociatedwith
SLE and RA in the general US population [1, 15–21]. It is
important to understand potential factors that may increase
the risk of these complex diseases, especially when military2 Autoimmune Diseases
deployments may include unique environmental and occu-
pational exposures [10, 22]. Using data from the Millennium
Cohort Study, these medical outcomes were prospectively
investigated in relation to demographic, occupational, and
behavioral characteristics.
2.MaterialsandMethods
2.1. Study Population. Participants were from the Millen-
nium Cohort Study, a prospective, population-based sample
consisting of a weighted random sample of all US service
members on rosters as of October 2000 and October 2003,
who were enrolled beginning in 2001 and 2004, respectively.
The Cohort was primarily designed to evaluate long-term
health eﬀects related to military service over a 21-year time
period. This study includes participants from the 2001 and
2004 enrollment cycles. A more detailed description of the
MillenniumCohortStudyhasbeenpublishedelsewhere[23–
25].
For the 2001 enrollment, a total of 77,047 participants
voluntarily consented and completed the baseline question-
naire (2001–2003), with 63,372 completing at least one of
the follow-up questionnaires (2004–2006, 2007-2008). For
the 2004 enrollment, 31,110 consented and completed the
baseline questionnaire (2004–2006) with 17,152 completing
the ﬁrst follow-up questionnaire (2007-2008). Of the 80,524
participants who completed the baseline and follow-up
questionnaires, exclusions included missing or aﬃrmative
self-report of lupus or RA at baseline, missing responses to
q u e s t i o n sr e l a t i n gt ol u p u so rR Ao na tl e a s to n ef o l l o w -
up questionnaire, self-reported disease at ﬁrst follow-up but
not at the second follow-up, self-reported disease prior to
ﬁrstdeployment,andaﬃrmativelyrespondedtoallprovider-
diagnosed disorders. This left a total population of 76,425
and 74,643 participants for the analyses of lupus and RA,
respectively.
2.2. Data Collection. Fixed and time-varying demographic
and military characteristics were obtained from the elec-
tronic personnel ﬁles maintained at the Defense Manpower
Data Center and linked to each participant at baseline and
each follow-up. Data included sex, birth year, race/ethnicity,
education, marital status, branch of service, service compo-
nent, military pay grade, military occupation, and deploy-
ment experience in support of the operations in Iraq and
Afghanistan from 2001 to 2008.
Participants were deﬁned as deployers at baseline if they
had deployed for 1 or more days in support of operations
in Iraq and Afghanistan prior to baseline and were deﬁned
as deployers at each follow-up if they were deployed for
1 or more days between follow-up survey assessments.
Deployers were further classiﬁed as with or without combat
experiences on each follow-up based on a positive self-report
to personally witnessing or being exposed in the past 3 years
to a person’s death due to war or disaster, physical abuse,
dead or decomposing bodies, maimed soldiers or civilians,
or prisoners of war or refugees. Combat experiences were
not assessed at baseline due to uncertainty of deployment-
exposure relation because the question was addressed in the
context of “ever” rather than the “past 3 years.” Participants
not meeting the deployment deﬁnition were considered
nondeployers.
Using baseline and follow-up surveys, time-varying gen-
eral health, behavioral, and occupational characteristics were
included to evaluate whether certain subpopulations were
more likely to newly report lupus or RA. General health was
investigated using the physical and mental component sum-
mary scores from the Medical Outcomes Study Short Form
36-Item Health Survey for Veterans [26–31]. Participants’
componentscoreswerecategorizedintoquartiles.Bodymass
index was classiﬁed as normal/underweight (<25kg/m2),
overweight (25 to <30kg/m2), and obese (≥30kg/m2). Non-
smokers, past smokers, and current smokers were identiﬁed
using survey questions addressing lifetime smoking of at
least 100 cigarettes (5 packs), a successful attempt to quit
smoking, and cigarette use in the past year. Alcohol misuse
was evaluated using the CAGE questionnaire (cutting down,
annoyance by criticism, guilty feeling, and eye openers)
[32, 33]. Finally, environmental and occupational exposures
were derived from an aﬃrmative self-report of ever being
exposed prior to newly reporting disease to the follow-
ing: chemical and biological warfare agents, occupational
hazards requiring personal protective equipment; routine
skin contact with paint, solvents, or substances, microwaves
(excluding microwave ovens), and topical (creams, sprays,
uniform treatments) and environmental pesticides.
2.3. Outcomes. Lupus and RA were investigated using the
baseline survey question “Has your doctor or other health
professional ever told you that you have any of the following
conditions?” At follow-up, participants were asked the same
question, but in the context of “in the last 3 years.” Newly
reported lupus and RA were deﬁned as an aﬃrmative self-
report to these diseases on either of the follow-up surveys
among participants reporting no prior condition. Those
who did not report an outcome of interest constituted the
nondiseased control comparison groups.
2.4. Statistical Analyses. Descriptive and univariate analyses
were conducted to examine unadjusted associations of
the study outcomes with demographic, occupational, and
behavioral risk factors. Separate models were developed for
both newly reported lupus and RA. Longitudinal analyses
were performed using the generalized estimating equa-
tions method to compare the adjusted association between
deployment status and both outcomes [34, 35]. All analyses
adjusted for time calculated as the number of years between
baseline and each follow-up survey. A model analysis was
performed using a variation inﬂation factor greater than
four to indicate a potential problem with multicollinear-
ity. Confounders were deﬁned as variables changing the
association between each disease outcome and deployment
status by more than 10% [36]. Variables that were not
confounders nor statistically signiﬁcant in the model at P
< 0.05 were manually removed using a backward reduction
method toestablishtheﬁnalmodels. Ifavariablewasneither
confounding nor signiﬁcant but was consistently associated
with either outcome in previous published literature, theAutoimmune Diseases 3
variable remained in the model. Statistical analyses were
performed using SAS software version 9.2 (SAS Institute,
Inc., Cary, NC, USA).
3. Results
3.1. Lupus. Baseline characteristics and deployment status
stratiﬁed by whether participants reported lupus at follow-
up are shown in Table 1. Over an average of 5.6 years
between baseline and last follow-up, the cumulative inci-
dence of lupus was 0.34 per 1000 person-years. Lupus was
newly reported among 0.2% of nondeployers and 0.1% of
deployers. Deployers were proportionately more likely to be
male,younger,lesseducated,andintheArmycomparedwith
nondeployers.
The results from the univariate analysis and the ﬁnal
adjusted model are shown in Table2. Subgroups proportion-
ately more likely to newly report lupus were female, non-
Hispanic black and Hispanic, not married, and of lower
mental and physical health. The following variables were
removed from the full adjusted model (not shown), because
they were not signiﬁcant (P>0.05) and did not confound
the results: education, marital status, service component,
pay grade, service branch, occupation, body mass index,
smokingstatus,alcoholmisuseandexposuretochemicaland
biological warfare agents, occupational hazards requiring
personal protective equipment, skin contact with paints,
solvents, or substances, microwaves (excluding microwave
ovens), and topical and environmental pesticides. The ﬁnal
adjusted model revealed deployments with and without
combat exposures were not signiﬁcantly associated with
newly reported lupus when compared with nondeployers
(P = 0.37).Womenwerenearlytwiceaslikely(adjustedodds
ratio(AOR) = 1.81, 95% conﬁdenceinterval [CI]:1.20–2.72)
to newly report lupus compared with men. Non-Hispanic
black (AOR = 2.66, 95% CI: 1.70–4.17) and Hispanic (AOR
= 2.35, 95% CI: 1.27–4.36) participants had over two times
the risk of newly reported lupus than non-Hispanic white
participants. Those reporting low mental and physical health
were at signiﬁcantly higher risk of newly reported lupus
whencomparedwiththosereportinghighmentalorphysical
health (>75th percentile).
3.2. Rheumatoid Arthritis. Baseline characteristics and
deployment status stratiﬁed by whether participants report-
ed RA at follow-up are shown in Table 1. The cumulative
incidence of RA between 2001 and 2008 was 3.30 per 1000
person-years. RA was newly reported among 1.9% of non-
deployers and 1.1% of deployers. Similar to lupus deployers
were proportionately more likely to be male, younger, less
educated, and in the Army compared with nondeployers.
Results for the univariate analysis and the ﬁnal adjusted
model are shown in Table 3. Subgroups proportionately
more likely to newly report RA were female, non-Hispanic
black and Hispanic, less educated, overweight, past and
current smokers, alcohol misusers, of lower mental and
physical health, having had unknown exposure to occu-
pational hazards requiring personal protective equipment,
and having had exposure to skin contact with paints,
solvents, or substances; microwaves; and environmental or
topical pesticides. To establish the ﬁnal model, the following
covariates were removed from the full model (not shown),
because they were not signiﬁcant (P>0.05) and were
not determined to be confounders: marital status, alcohol
misuse, and exposure to occupational hazards requiring
personal protective equipment, routine skin contact with
paints, solvents, or substances, and environment and topical
pesticides. The ﬁnal adjusted model revealed those deployed
with (AOR = 0.74, 95% CI: 0.62–0.88) and without (AOR =
0.59,95%CI:0.48–0.73)combatexposuresweresigniﬁcantly
lesslikelytonewlyreportRA.Thosesigniﬁcantlylesslikelyto
newly report RA were younger; Reserve or National Guard;
oﬃcers; Air Force, Navy, or Coast Guard; and health care
specialists. Women were 1.26 (95% CI: 1.08–1.47) times
more likely to report RA than men. Non-Hispanic black
(AOR = 1.77, 95% CI: 1.51–2.08) and Hispanic (AOR =
1.40, 95% CI: 1.11–1.76) participants had a signiﬁcantly
higher risk of disease compared with non-Hispanic white
participants. Those with some college, obese respondents,
andcurrentandpastsmokersalsohadasigniﬁcantlyelevated
risk of RA. Lower mental and physical health, exposure
to chemical and biological warfare agents, and “do not
know” response to exposure to microwaves were signiﬁ-
cantly associated with an increased risk of newly reported
RA.
4. Discussion
Concern was raised after the 1991 Gulf War [13, 14]o f
a possible association between service in this conﬂict and
a higher risk of SLE and RA. This potential association
continues to be of interest in light of stressful military
deployments currently in Iraq and Afghanistan [7–9, 11,
25, 37, 38]. This is the ﬁrst study to prospectively docu-
ment, in a large population-based military cohort, newly
reported lupus and RA in the context of deployment while
diﬀerentiating stresses of combat experiences. Compared
with nondeployers, deployment with and without combat
exposures was not found to be a signiﬁcant risk factor
for newly reported lupus. However, deployment with and
without combat exposures was signiﬁcantly associated with
a decreased risk of newly reported RA compared with
nondeployers. To better assess the full eﬀects associated
with stressful exposures during deployment, deployers with
combat exposures were compared with deployers without
combat exposures. Compared with noncombat deployers,
those with combat exposures had an increased risk of newly
reported RA though not signiﬁcant (AOR = 1.24, 95% CI:
0.96–1.61). This may indicate a stress-induced pathway that
elevates the risk for RA among deployers who experience
combat [12, 39, 40]. Though long-term follow-up of the
Cohort will yield further insight into deployment-related
eﬀects, these results are reassuring that compared with
nondeployers, there is no apparent increase in risk for newly
reported lupus or RA in relation to deployment in support of
Iraq and Afghanistan.
The cumulative incidence of lupus reported in this study
was elevated compared with previous reports for the US4 Autoimmune Diseases
Table 1: Baseline∗ characteristics of Millennium Cohort participants with newly reported lupus and rheumatoid arthritis (2001–2008).
Characteristics
Lupus Rheumatoid arthritis
Disease No disease Disease No disease
n = 115 n = 72,576 n = 1,100 n = 69,924
n %† n %† n %† n %†
Deployment‡
Nondeployed 75 65.2 39,874 54.9 744 67.6 38,111 54.5
Deployed without combat 22 19.1 17,985 24.7 174 15.8 17,594 25.2
Deployed with combat§ 18 15.7 14,717 20.3 182 16.6 14,219 20.3
Sex
Male 56 48.7 51,240 70.6 760 69.1 49,321 70.5
Female 59 51.3 21,336 29.4 340 30.9 20,603 29.5
Birth year
Before 1960 22 19.1 13,686 18.9 381 34.6 12,629 18.1
1960–1969 41 35.7 24,131 33.3 470 42.7 22,996 32.9
1970–1979 41 35.7 24,020 33.1 197 17.9 23,645 33.8
1980 and later 11 9.6 10,739 14.8 52 4.7 10,654 15.2
Race/ethnicity
Non-Hispanic white 58 50.4 51,610 71.1 673 61.2 49,882 71.3
Non-Hispanic black 32 27.8 8,723 12.0 244 22.2 8,214 11.8
Hispanic 13 11.3 4,883 6.7 90 8.2 4,718 6.8
Other 12 10.4 7,360 10.1 93 8.5 7,110 10.2
Education
High school or less 67 58.3 37,153 51.2 572 52.0 35,815 51.2
Some college 25 21.7 15,797 21.8 297 27.0 15,061 21.5
Bachelor’s or higher degree 23 20.0 19,626 27.0 231 21.0 19,048 27.2
Marital status
Married 66 57.4 42,522 58.6 793 72.1 40,514 57.9
Not married 49 42.6 30,054 41.4 307 27.9 29,410 42.1
Service component
Active duty 64 55.7 40,745 56.1 640 58.2 39,235 56.1
Reserve/Guard 51 44.4 31,831 43.9 460 41.8 30,689 43.9
Military pay grade
Enlisted 97 84.4 55,262 76.1 935 85.0 53,068 75.9
Oﬃcer 18 15.7 17,314 23.9 165 15.0 16,856 24.1
Service branch
Army 63 54.8 33,856 46.7 619 56.3 32,349 46.3
Air Force 30 26.1 21,557 29.7 272 24.7 20,924 29.9
Marine Corps 4 3.5 3,880 5.4 43 3.9 3,765 5.4
Navy/Coast Guard 18 15.7 13,283 18.3 166 15.1 12,886 18.4
Occupation
Combat specialist 16 13.9 14,058 19.4 185 16.8 13,588 19.4
Health care specialist 23 20.0 8,259 11.4 90 8.2 8,054 11.5
Functional support 33 28.7 14,085 19.4 291 26.5 13,428 19.2
Electrical/mechanical 12 10.4 10,156 14.0 155 14.1 9,744 13.9
Service support 10 8.7 6,433 8.9 125 11.4 6,139 8.8
Other 21 18.3 19,585 27.0 254 23.1 18,971 27.1
Body mass index (kg/m2)
Normal/underweight (<25) 56 48.7 29,520 40.7 320 29.1 28,790 41.2
Overweight (25 to <30) 45 39.1 35,874 49.4 604 54.9 34,441 49.3
Obese (≥30) 14 12.2 7,182 9.9 176 16.0 6,693 9.6
Smoking status
Nonsmoker 68 59.1 42,572 58.7 552 50.1 41,285 59.0
Past smoker 21 18.3 17,425 24.0 321 29.2 16,613 23.8
Current smoker 26 22.6 12,579 17.3 228 20.7 12,026 17.2Autoimmune Diseases 5
Table 1: Continued.
Characteristics
Lupus Rheumatoid arthritis
Disease No disease Disease No disease
n = 115 n = 72,576 n = 1,100 n = 69,924
n %† n %† n %† n %†
Alcohol misuse¶
No 91 79.1 58,901 81.2 894 81.3 56,766 81.2
Yes 24 20.9 13,675 18.8 206 18.7 13,158 18.8
Mental component score
>75th percentile 26 22.6 20,760 28.6 299 27.2 19,974 28.6
>50th to 75th percentile 27 23.5 17,759 24.5 248 22.6 17,166 24.6
>25th to 50th percentile 23 20.0 16,266 22.4 182 16.6 15,721 22.5
0 to 25th percentile 39 33.9 17,791 24.5 371 33.7 17,063 24.4
Physical component score
>75th percentile 20 17.4 20,307 28.0 124 11.3 19,756 28.3
>50th to 75th percentile 26 22.6 18,245 25.1 168 15.3 17,664 25.3
>25th to 50th percentile 22 19.1 17,135 23.6 256 23.3 16,552 23.7
0 to 25th percentile 47 40.9 16,889 23.3 552 50.2 15,952 22.8
Chemical and/or biological warfare agents
No 106 92.2 68,750 94.7 968 88.0 66,446 95.0
Yes, 1 or more times 9 7.8 3,826 5.3 132 12.0 3,478 5.0
Hazards requiring personal protective equipment
No 65 56.5 31,622 43.6 476 43.3 30,558 43.7
Yes 46 40.0 39,420 54.3 584 53.1 37,921 54.2
Do not know 4 3.5 1,534 2.1 40 3.6 1,445 2.1
Routine skin contact with paint, solvents, substances
No 74 64.4 50,431 69.5 669 60.8 48,912 70.0
Yes 33 28.7 19,276 26.6 363 33.0 2,719 3.9
Do not know 8 7.0 2,869 4.0 68 6.2 2,719 3.9
Microwaves (excluding microwave ovens)
No 83 72.2 53,942 74.3 718 65.3 52,253 74.7
Yes 24 20.9 12,818 17.7 232 21.1 12,165 17.4
Do not know 8 7.0 5,816 8.0 150 13.6 5,506 7.9
Pesticides (creams, sprays, uniform treatments)
No 71 61.7 46,506 64.1 606 55.1 45,091 64.5
Yes 35 30.4 19,652 27.1 378 34.4 18,709 26.8
Do not know 9 7.8 6,418 8.8 116 10.6 6,124 8.8
Pesticides (environment, living facilities)
No 63 54.8 42.194 58.1 523 47.6 40,985 58.6
Yes 37 32.2 20,508 28.3 410 37.3 19,462 27.8
Do not know 15 13.0 9,874 13.6 167 15.2 9,477 13.6
∗Population excludes participants with missing baseline covariates, may not represent whole study population.
†Percentages may not sum to 100 because of rounding.
‡Deployed in support of the operations in Iraq and Afghanistan.
§Self-report of personally witnessing or being exposed to a person’s death due to war or disaster, physical abuse, dead and/or decomposing bodies, maimed
soldiers or civilians, prisoners of war, or refugees.
¶Alcohol misuse is deﬁned as at least 1 positive response to the CAGE questions (i.e., Cutting down, Annoyance by criticism, Guilty feeling, and Eye-openers)
[32, 33].
population (systemic lupus erythematosus: 0.02 to 0.08 per
1000 person-years) [41–43]. It is diﬃcult to compare these
rates, because military personnel may have been exposed
to unique environmental and occupational risk factors not
typically experienced in the general population. However,
misclassiﬁcation of this disorder may have occurred, because
participants reporting lupus may have been diagnosed with
any form of lupus and not SLE speciﬁcally. This is due to
the questionnaire not restricting which type of lupus to be
reported.6 Autoimmune Diseases
Table 2: Odds of newly reported lupus and military deployment, the Millennium Cohort Study (N=77,811).
Characteristics Unadjusted Final model∗ Conﬁrmed case model†
OR 95% CI AOR‡ 95% CI AOR‡ 95% CI
Deployment§
Nondeployed 1.00¶ 1.00¶ 1.00¶
Deployed without combat 0.85 0.53–1.35 0.91 0.55–1.50 0.28 0.04–1.82
Deployed with combat# 0.64 0.37–1.09 0.66 0.37–1.19 0.32 0.05–2.11
Sex
Male 1.00¶ 1.00¶ 1.00¶
Female 2.42 1.69–3.48 1.81 1.20–2.72 4.24 1.14–15.81
Birth year
Before 1960 1.00¶ 1.00¶ 1.00¶
1960–1969 1.23 0.74–2.04 1.26 0.75–2.11 0.73 0.08–6.67
1970–1979 1.36 0.82–2.27 1.44 0.86–2.44 0.51 0.05–5.22
1980 and later 1.23 0.60–2.51 1.13 0.54–2.37 1.22 0.10–15.21
Race/ethnicity
Non-Hispanic white 1.00¶ 1.00¶ 1.00¶
Non-Hispanic black 3.24 2.12–4.95 2.66 1.70–4.17 2.41 0.60–9.71
Hispanic 2.47 1.35–4.54 2.35 1.27–4.36 1.15 0.13–10.30
Other 1.29 0.69–2.41 1.38 0.74–2.58 0.72 0.09–6.01
Education
High school or less 1.00¶
Some college 1.41 0.93–2.14
Bachelor’s or higher degree 0.87 0.57–1.31
Marital status
Married 1.00¶
Not married 1.67 1.18–2.35
Service component
Active duty 1.00¶
Reserve/Guard 0.85 0.60–1.21
Military pay grade
Enlisted 1.00¶
Oﬃcer 0.58 0.37–0.91
Service branch
Army 1.00¶
Air Force 0.69 0.47–1.06
Marine Corps 0.80 0.32–2.00
Navy/Coast Guard 0.77 0.47–1.28
Occupation
Functional support 1.00¶
Combat specialist 0.53 0.28–1.00
Health care specialist 1.25 0.73–2.13
Electrical/mechanical 0.73 0.40–1.35
Service support 0.71 0.37–1.35
Other 0.67 0.40–1.11
Body mass index (kg/m2)
Normal/underweight (<25) 1.00¶
Overweight (25 to <30) 0.82 0.56–1.20
Obese (≥30) 1.44 0.93–2.24
Smoking status
Nonsmoker 1.00¶
Past smoker 1.04 0.69–1.57
Current smoker 1.27 0.77–2.09Autoimmune Diseases 7
Table 2: Continued.
Characteristics Unadjusted Final model∗ Conﬁrmed case model†
OR 95% CI AOR‡ 95% CI AOR‡ 95% CI
Alcohol misuse∗∗
No 1.00¶
Yes 1.13 0.75–1.71
Mental component score
>75th percentile 1.00¶ 1.00¶
>50th to 75th percentile 1.16 0.72–1.85 1.25 0.75–2.07
>25th to 50th percentile 0.84 0.50–1.42 0.89 0.52–1.53
0 to 25th percentile 1.96 1.26–3.05 1.68 1.06–2.66
Physical component score
>75th percentile 1.00¶ 1.00¶
>50th to 75th percentile 0.97 0.51–1.84 1.08 0.55–2.14
>25th to 50th percentile 1.73 0.95–3.14 1.79 0.96–3.34
0 to 25th percentile 4.27 2.50–7.29 4.34 2.51–7.49
Chemical/biological warfare agents
No 1.00¶
Yes, 1 more times 0.68 0.45–1.02
Hazards requiring personal protective equipment
No 1.00¶
Yes 0.70 0.49–1.01
Do not know 1.21 0.43–3.38
Routine skin contact with paint, solvents, substances
No 1.00¶
Yes 1.18 0.81–1.73
Do not know 2.20 1.12–4.32
Microwaves (excluding microwave ovens)
No 1.00¶
Yes 1.07 0.69–1.67
Do not know 1.40 0.82–2.42
Pesticides (creams, sprays, uniform treatments)
No 1.00¶
Yes 1.17 0.81–1.69
Do not know 0.87 0.44–1.73
Pesticides (environment, living facilities)
No 1.00¶
Yes 1.15 0.79–1.66
Do not know 1.02 0.58–1.78
Time (years) 1.42 1.31–1.55 1.38 1.26–1.50 1.42 1.08–1.88
AOR, adjusted odds ratio; CI, conﬁdence interval; OR, odds ratio.
∗Final model established by removing nonsigniﬁcant, nonconfounding covariates from the full model.
†Conﬁrmed cases model is among active-duty, nonseparated participants. There were not enough conﬁrmed cases for mental and physical component scores
to be tested in the model.
‡Adjusted odds ratios and associated 95% conﬁdence intervals are adjusted for all other variables in the table.
§Deployed in support of the operations in Iraq and Afghanistan.
¶Indicates reference category.
#Self-report of personally witnessing or being exposed to a person’s death due to war or disaster, physical abuse, dead and/or decomposing bodies, maimed
soldiers or civilians, prisoners of war, or refugees.
∗∗Alcohol misuse is deﬁned as at least 1 positive response to the CAGE questions (i.e., cutting down, annoyance by criticism, guilty feeling, and eye-openers)
[32, 33].8 Autoimmune Diseases
Table 3: Odds of newly reported rheumatoid arthritis and military deployment, the Millennium Cohort Study (N=76,003).
Characteristics Unadjusted Final model∗ Conﬁrmed case model†
OR 95% CI AOR‡ 95% CI AOR‡ 95% CI
Deployment§
Nondeployed 1.00¶ 1.00¶ 1.00¶
Deployed without combat 0.47 0.39–0.56 0.59 0.48–0.73 0.70 0.33–1.49
Deployed with combat# 0.69 0.59–0.81 0.74 0.62–0.88 0.83 0.38–1.77
Sex
Male 1.00¶ 1.00¶ 1.00¶
Female 1.16 1.02–1.31 1.26 1.08–1.47 1.96 0.88–4.37
Birth year
Before 1960 1.00¶ 1.00¶ 1.00¶
1960–1969 0.72 0.63–0.82 0.64 0.55–0.74 0.94 0.30–2.95
1970–1979 0.33 0.27–0.39 0.31 0.26–0.38 0.32 0.09–1.20
1980 and later 0.29 0.22–0.39 0.26 0.19–0.35 0.37 0.08–1.78
Race/ethnicity
Non-Hispanic white 1.00¶ 1.00¶ 1.00¶
Non-Hispanic black 2.27 1.97–2.62 1.77 1.51–2.08 0.58 0.21–1.60
Hispanic 1.49 1.20–1.85 1.40 1.11–1.76 1.17 0.41–3.36
Other 0.92 0.74–1.13 1.00 0.79–1.27 1.26 0.42–3.78
Education
High school or less 1.00¶ 1.00¶ 1.00¶
Some college 1.67 1.47–1.91 1.21 1.05–1.39 1.91 0.92–3.94
Bachelor’s or higher degree 0.88 0.76–1.01 1.10 0.93–1.30 1.57 0.64–3.88
Marital status
Married 1.00¶
Not married 0.98 0.87–1.11
Service component
Active duty 1.00¶ 1.00¶ 1.00¶
Reserve/Guard 0.83 0.74–0.93 0.73 0.64–0.83 0.14 0.02–1.35
Military pay grade
Enlisted 1.00¶ 1.00¶ 1.00¶
Oﬃcer 0.45 0.39–0.53 0.60 0.48–0.74 0.17 0.05–0.61
Service branch
Army 1.00¶ 1.00¶
Air Force 0.63 0.55–0.73 0.79 0.67–0.92
Marine Corps 0.71 0.53–0.96 1.01 0.74–1.37
Navy/Coast Guard 0.67 0.57–0.79 0.74 0.62–0.89
Occupation
Functional support 1.00¶ 1.00¶ 1.00¶
Combat specialist 0.80 0.66–0.96 1.09 0.90–1.32 0.78 0.26–2.35
Health care specialist 0.60 0.48–0.76 0.66 0.52–0.85 0.50 0.16–1.55
Electrical/mechanical 1.03 0.85–1.24 1.07 0.87–1.36 1.12 0.46–2.74
Service support 1.19 0.97–1.44 1.11 0.91–1.36 1.52 0.56–4.12
Other 0.87 0.74–1.02 1.00 0.85–1.19 0.40 0.16–0.97
Body mass index (kg/m2)
Normal/Underweight (<25) 1.00¶ 1.00¶ 1.00¶
Overweight (25 to <30) 1.34 1.16–1.54 1.11 0.95–1.29 0.77 0.38–1.56
Obese (≥30) 2.41 2.07–2.80 1.41 1.20–1.67 1.20 0.49–2.91
Smoking status
Nonsmoker 1.00¶ 1.00¶ 1.00¶
Past smoker 1.39 1.22–1.58 1.13 0.99–1.30 1.63 0.84–3.14
Current smoker 1.54 1.33–1.80 1.19 1.02–1.40 0.56 0.20–1.56Autoimmune Diseases 9
Table 3: Continued.
Characteristics Unadjusted Final model∗ Conﬁrmed case model†
OR 95% CI AOR‡ 95% CI AOR‡ 95% CI
Alcohol misuse∗∗
No 1.00¶
Yes 1.18 1.04–1.36
Mental component score
>75th percentile 1.00¶ 1.00¶ 1.00¶
>50th to 75th percentile 0.73 0.62–0.85 0.89 0.75–1.06 0.72 0.35–1.48
>25th to 50th percentile 0.87 0.75–1.02 1.04 0.88–1.23 0.73 0.36–1.49
0 to 25th percentile 1.67 1.46–1.92 1.64 1.42–1.91 0.85 0.42–1.70
Physical component score
>75th percentile 1.00¶ 1.00¶ 1.00¶
>50th to 75th percentile 1.40 1.05–1.86 1.38 1.02–1.88 1.34 0.37–4.83
>25th to 50th percentile 2.99 2.30–3.90 2.72 2.06–3.61 2.56 0.78–8.35
0 to 25th percentile 12.25 9.60–15.63 9.03 6.95–11.74 7.89 2.48–25.10
Chemical/biological warfare agents
No 1.00¶ 1.00¶ 1.00¶
Yes, 1 or more times 0.98 0.85–1.12 1.47 1.22–1.78 1.43 0.49–4.18
Hazards requiring personal protective equipment
No 1.00¶
Yes 0.96 0.85–1.07
Do not know 1.59 1.17–2.18
Routine skin contact with paint, solvents, substances
No 1.00¶
Yes 1.39 1.24–1.56
Do not know 1.74 1.38–2.19
Microwaves (excluding microwave ovens)
No 1.00¶ 1.00¶ 1.00¶
Yes 1.44 1.26–1.64 1.14 0.99–1.31 0.80 0.36–1.78
Do not know 1.63 1.38–1.92 1.25 1.05–1.50 1.58 0.60–4.16
Pesticides (creams, sprays, uniform treatments)
No 1.00¶
Yes 1.39 1.24–1.57
Do not know 1.36 1.13–1.64
Pesticides (environment, living facilities)
No 1.00¶
Yes 1.47 1.30–1.65
Do not know 1.22 1.04–1.45
Time (years) 1.44 1.40–1.48 1.31 1.27–1.35 1.19 0.99–1.44
AOR, adjusted odds ratio; CI, conﬁdence interval; OR, odds ratio.
∗Final model established by removing nonsigniﬁcant, nonconfounding covariates from the full model.
†Conﬁrmedcasesmodelisamongactive-duty,nonseparatedparticipants.Therewerenotenoughconﬁrmedcasesforservicebranchtobetestedinthemodel.
‡Adjusted odds ratios and associated 95% conﬁdence intervals are adjusted for all other variables in the table.
§Deployed in support of the operations in Iraq and Afghanistan.
¶Indicates reference category.
#Self-report of personally witnessing or being exposed to a person’s death due to war or disaster, physical abuse, dead and/or decomposing bodies, maimed
soldiers or civilians, prisoners of war, or refugees.
∗∗Alcohol misuse is deﬁned as at least 1 positive response to the CAGE questions (i.e., cutting down, annoyance by criticism, guilty feeling, and eye-openers)
[32, 33].
Previous literature has documented that environmen-
tal and occupational exposures were associated with an
increased risk of lupus [16, 18–20]; however, these predictors
were not strong risk factors for lupus development in this
study and were not included in the ﬁnal model. Though
incidence rates have been reported to be much higher for
women, and non-Hispanic black and Hispanic participants
in the US population [3, 41, 43, 44], the incidence of10 Autoimmune Diseases
lupus has not been thoroughly investigated in a military
population, making an appropriate comparison diﬃcult.
Despite these diﬀerences, lower mental and physical health
was associated with increased risk of lupus, which was
consistent with previous research in the US population
[45].
Similar to lupus, there was a higher cumulative incidence
of self-reported RA in this study compared with previous
results in the US population (0.24 to 0.68 per 1000 person-
years) [1, 5, 42]. This may be a result of those with any
form of arthritis endorsing RA, as the questionnaire did
not provide a deﬁnition of RA. Also, the incidence rates for
women and non-Hispanic black and Hispanic participants
have been reported higher for the US population than in the
currentstudy[1,5].Theseﬁndings,however,wereconsistent
withpreviousreportsofgreaterRAriskassociatedwithlower
mental and physical health status [45, 46], higher body mass
index [1, 47, 48], smoking [1, 47, 48], and less education
[1, 47]. Additionally, the documented average age of new-
onsetRAisbetween30and55y earsofageamongthegeneral
population [1], and the current study consistently found a
lower risk associated with younger age.
To our knowledge, an increased risk of RA among those
self-reporting exposure to chemical or biological warfare
agents has not been reported. Due to the lack of evidence of
chemical or biological warfare agents existing in the current
operations in Iraq and Afghanistan, this association may
be a self-perceived exposure or the result of overreporting
bias. In addition, the association between RA and exposure
to microwaves (excluding microwave ovens) has not been
documented. While in vivo and in vitro studies suggest low
exposures to microwaves may cause changes in the immune
system, and neurological and behavioral eﬀects, the true
biological responses due to microwave exposures are still
under investigation [49].
This study had several limitations. The current analyses
used self-reported data from the Millennium Cohort ques-
tionnaire; however, previous studies of this Cohort suggest it
is representative of US military personnel, the data reported
by its participants are reliable and were unaﬀected by the
participant’shealthstatuspriortoenrollment[22,23,36,50–
57]. Also, the questionnaire did not specify which type of
lupus or deﬁne RA which may have resulted in misclassi-
ﬁcation of both outcomes. With a large sample size and
population-based design, conducting clinical examinations
to conﬁrm self-reported diagnoses was not feasible. The
documented validity of self-reported provider-diagnosed
data varies widely for lupus (21%–84%) and RA (7%–96%)
[58–63]. Therefore, an electronic medical records review
was performed for both outcomes using ICD-9 codes in
Armed Forces Health Longitudinal Technology Application
andMilitaryHealthSystemdatabases.Thisreviewcouldonly
be conducted for active-duty members diagnosed while in
service. Conﬁrmation of 13 out of 33 (39.4%) lupus and 39
out of 281 (13.9%) RA self-reported diagnoses were found.
Thus, there may be substantial misclassiﬁcation of both
outcomes. The sensitivity analyses among the conﬁrmed
diagnoses resulted in stability of the measures of association
betweendeploymentandlupusandRA(see“Conﬁrmedcase
models”, Tables 2 and 3).
Another important limitation was lupus and RA are
rare outcomes resulting in few newly reported cases occur-
ring during the average 5.6 years of follow-up. This may
ultimately aﬀect the precision of the estimates that will
only be lessened with additional follow-up and subsequent
cases. Also, deployment included those deployed for 1 or
more days, so those on shorter deployments had fewer days
exposed than those on longer deployments. Furthermore,
deployed participants that did not aﬃrmatively respond
to the questions deﬁning combat exposure may have been
exposed to combat situations that were not addressed in this
study including receiving small arms ﬁre, or being attacked
or ambushed. Lastly, the Millennium Cohort Study does
not obtain information on diet, family history, genetic risk
factors, or medication, making it diﬃcult to thoroughly
examine these exposures as possible risk factors for these
diseases.
Despite these limitations, this study has several strengths.
This is the ﬁrst study to prospectively investigate whether
military deployment status is associated with newly reported
provider-diagnosis of lupus and RA, while also being able to
evaluate speciﬁc military exposures and adjust for negative
health behaviors such as alcohol misuse and tobacco use.
Additionally, the prospective design of the Cohort allowed
for assessment at baseline and follow-up of the same
individuals accounting for time-varying covariates. Lastly,
a large sample size, representing both men and women,
all branches of the military, active duty, and Reserve and
NationalGuardpersonnelduringandafterservice,enhanced
statistical power for assessing these chronic diseases while
considering multiple potential confounders.
In conclusion, newly reported lupus was not associated
with military deployment in support of the current oper-
ations in Iraq and Afghanistan when compared with non-
deployers. These ﬁndings, however, suggest a signiﬁcantly
decreased risk of newly reported RA for deployers with and
without combat exposures and may be due to a selection
eﬀect for deployment. Demographic and general health
characteristics and speciﬁc exposures were also associated
with lupus and RA development in this population. While
this study did not ﬁnd deployment to be a signiﬁcant risk
factor for development of lupus or RA, it is important to
further investigate these associations in the future, as the
incidence of lupus and RA may progress over time. This
study highlights the strengths of prospectively addressing
long-term health concerns associated with occupational and
environmental exposures among military personnel.
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